Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · IEX Real-Time Price · USD
1.080
+0.441 (69.01%)
At close: Mar 28, 2024, 4:00 PM
1.300
+0.220 (20.37%)
After-hours: Mar 28, 2024, 7:59 PM EDT
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $29.73 million as of March 28, 2024. Its market cap has decreased by -63.92% in one year.
Market Cap
29.73M
Enterprise Value
-17.23M
1-Year Change
-63.92%
Ranking
Category
Stock Price
$1.08
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $29.73M, a decrease of -93.03%. That is a compound annual growth rate of -66.54%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2024 | 29.70M | 68.75% |
Mar 27, 2024 | 17.60M | -3.30% |
Mar 26, 2024 | 18.20M | -5.70% |
Mar 25, 2024 | 19.30M | -1.03% |
Mar 22, 2024 | 19.50M | 0.52% |
Mar 21, 2024 | 19.40M | 2.11% |
Mar 20, 2024 | 19.00M | 0.53% |
Mar 19, 2024 | 18.90M | 1.07% |
Mar 18, 2024 | 18.70M | -1.06% |
Mar 15, 2024 | 18.90M | 6.18% |
Mar 14, 2024 | 17.80M | -7.77% |
Mar 13, 2024 | 19.30M | 4.32% |
Mar 12, 2024 | 18.50M | -11.06% |
Mar 11, 2024 | 20.80M | -9.17% |
Mar 8, 2024 | 22.90M | 4.09% |
Mar 7, 2024 | 22.00M | -2.65% |
Mar 6, 2024 | 22.60M | 3.20% |
Mar 5, 2024 | 21.90M | 8.96% |
Mar 4, 2024 | 20.10M | 1.52% |
Mar 1, 2024 | 19.80M | 1.54% |
Feb 29, 2024 | 19.50M | 7.14% |
Feb 28, 2024 | 18.20M | 5.81% |
Feb 27, 2024 | 17.20M | 4.24% |
Feb 26, 2024 | 16.50M | 3.13% |
Feb 23, 2024 | 16.00M | 5.96% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
PAVmed | 18.84M |
Check-Cap | 18.72M |
Pieris Pharmaceuticals | 18.62M |
CareCloud | 18.42M |
CareMax | 18.33M |
Minerva Neurosciences | 17.76M |
NeurAxis | 17.67M |
Alterity Therapeutics | 17.63M |